Katsuya Miki

This inventor holds 7 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Daicel Corporation, Mitsubishi Denki Kabushiki Kaisha. Active years: 2000-2026.

USPTO Granted Patents = 7 (Patent Applications = 5)

% Patents Active = 71.4

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 30(Granted Patents)

Location History:

Osaka, JP (2023)
Tokyo, JP (2000 - 2024)

Company Filing History:

Mitsubishi Denki Kabushiki Kaisha

patents

Years Active: 2000-2026

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714791 - Injector (2026-08-25),

2. 12612583 - Device that introduces substance to cells (2026-04-28),

3. 12083320 - Injector and method of injecting solution containing biomolecules into injection target using the same (2024-09-10),

4. D1039685 - Needleless injector (2024-08-20),

5. 11672911 - Needleless injector, method of adjusting on-completion reached depth with needleless injector, and ejection parameter calculation program for needleless injector (2023-06-13),

6. D931439 - Control unit for needleless injector (2021-09-21),

7. 6144120 - Stepping motor for stable control of position of driven body (2000-11-07),

Title: Katsuya Miki: Innovator in Biomolecular Injection Technology

Introduction

Katsuya Miki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomolecular injection technology, holding a total of 7 patents. His innovative work focuses on improving the efficiency and effectiveness of injecting biomolecules into target areas.

Latest Patents

One of Katsuya Miki's latest patents is an injector and method of injecting a solution containing biomolecules into an injection target. This application relates to an injector designed to ensure that a larger proportion of biomolecules functions effectively within the injection target compared to the total amount injected. The injector operates by delivering the solution from the main body without requiring a specific structure to be inserted into the target during the injection process. The design includes an accommodation unit and a nozzle unit, which together meet specific operational conditions.

Career Highlights

Throughout his career, Katsuya Miki has worked with notable companies such as Daicel Corporation and Mitsubishi Denki Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas in biomolecular technology.

Collaborations

Katsuya Miki has collaborated with talented individuals in his field, including Hiromitsu Iga and Yosuke Morishita. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Katsuya Miki's work in biomolecular injection technology showcases his dedication to innovation and improvement in medical applications. His patents reflect a commitment to enhancing the effectiveness of biomolecular delivery systems.